According to Perkins and Will and the nonprofit Healthy Building Network, building products with antimicrobial treatments are not proved to be a safe or effective means of controlling the spread of COVID-19.
The two organizations issued a statement reaffirming the conclusion of their March 2017 white paper on antimicrobial building products: Antimicrobial additives have not been proven to have the health benefits they promote, and alternatives should be sought wherever possible. No scientific evidence exists that demonstrates any health benefits from antimicrobial additives in building products and materials. “There is no evidence that the addition of antimicrobials to building products lowers the rate of infection or that they lead to a healthier population,” said Teresa McGrath, HBN Chief Research Officer and Toxicologist. These products include textile, furnishings, flooring, tiles, and other surfaces and interior finishes.
It is quite the contrary, in fact, as evidence suggests that with repeated human exposure, antimicrobials can inadvertently contribute to the formation of “super bugs” that are resistant to medical treatment. Antimicrobial additives have also been shown to leach out of materials during use and enter drains and water treatment facilities. Some antimicrobials, such as nano silver, are considered toxic to humans and entire aquatic ecosystems. Another issue with antimicrobial products is that they can create a false sense of security, which may lead to a reduced role of proper cleaning and less-diligent facility maintenance.
Related Stories
Coronavirus | Apr 9, 2020
COVID-19 alert: Robins & Morton to convert Miami Beach Convention Center into a 450-bed field hospital
COVID-19 alert: Robins & Morton to convert Miami Beach Convention Center into a 450-bed field hospital
Coronavirus | Apr 8, 2020
AIA task force launches tool for assessing COVID-19 alternative care sites
The tool is intended to assist non-healthcare design professionals with identifying alternative sites suitable for patient care.
Coronavirus | Apr 8, 2020
COVID-19 alert: Most U.S. roofing contractors hit by coronavirus, says NRCA
NRCA survey shows 52% of roofing contractor said COVID-19 pandemic was having a significant or very significant impact on their businesses.
Coronavirus | Apr 8, 2020
Navigate supply chain and manufacturing challenges during disruption
First, most important and most complex: Create an extensive safety plan for your facilities and job sites that protects both the personnel onsite and the end users of your product.
Coronavirus | Apr 7, 2020
How to turn a high school into a patient care center in 15 days
HKS’s concept paper presents three scenarios.
Coronavirus | Apr 7, 2020
New Trump administration guidance now allows firms with 500 of fewer employees to qualify for paycheck protection program loans
Associated General Contractors of America secures fix to loan qualifications after alerting administration officials to small business administration language that excluded many firms.
Coronavirus | Apr 6, 2020
New small business administration loan guidance appears to exclude many construction firms that employ fewer than 500 people
Construction officials urge agency to make clear that firms that employ 500 or fewer people to qualify for paycheck protection program loans, regardless of revenue.
Coronavirus | Apr 6, 2020
Pandemic preparedness: How hospitals can adapt buildings to address worst-case scenarios
A Canadian healthcare architect looks at how hospital staff can act now to modify facilities and contain a pandemic.
Coronavirus | Apr 5, 2020
COVID-19: Most multifamily contractors experiencing delays in projects due to coronavirus pandemic
The NMHC Construction Survey is intended to gauge the magnitude of the disruption caused by the COVID-19 outbreak on multifamily construction.